{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:03:26Z","timestamp":1789614206973,"version":"build-2803163510"},"reference-count":48,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute","award":["HHSN261201200031I"],"award-info":[{"award-number":["HHSN261201200031I"]}]},{"name":"National Cancer Institute","award":["CA023074"],"award-info":[{"award-number":["CA023074"]}]},{"name":"Arizona Cancer Center Support Grant","award":["HHSN261201200031I"],"award-info":[{"award-number":["HHSN261201200031I"]}]},{"name":"Arizona Cancer Center Support Grant","award":["CA023074"],"award-info":[{"award-number":["CA023074"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The chemopreventive effect of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) on lung cancer risk is supported by epidemiologic and preclinical studies. Zileuton, a 5-lipoxygenase inhibitor, has additive activity with NSAIDs against tobacco carcinogenesis in preclinical models. We hypothesized that cyclooxygenase plus 5-lipoxygenase inhibition would be more effective than a placebo in modulating the nasal epithelium gene signatures of tobacco exposure and lung cancer. We conducted a randomized, double-blinded study of low-dose aspirin plus zileuton vs. double placebo in current smokers to compare the modulating effects on nasal gene expression and arachidonic acid metabolism. In total, 63 participants took aspirin 81 mg daily plus zileuton (Zyflo CR) 600 mg BID or the placebo for 12 weeks. Nasal brushes from the baseline, end-of-intervention, and one-week post intervention were profiled via microarray. Aspirin plus zilueton had minimal effects on the modulation of the nasal or bronchial gene expression signatures of smoking, lung cancer, and COPD but favorably modulated a bronchial gene expression signature of squamous dysplasia. Aspirin plus zileuton suppressed urinary leukotriene but not prostaglandin E2, suggesting shunting through the cyclooxygenase pathway when combined with 5-lipoxygenase inhibition. Continued investigation of leukotriene inhibitors is needed to confirm these findings, understand the long-term effects on the airway epithelium, and identify the safest, optimally dosed agents.<\/jats:p>","DOI":"10.3390\/cancers14122893","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T09:33:26Z","timestamp":1654940006000},"page":"2893","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Study of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers"],"prefix":"10.3390","volume":"14","author":[{"given":"Linda L.","family":"Garland","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Arizona, Tucson, AZ 85724, USA"},{"name":"University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Guillen-Rodriguez","sequence":"additional","affiliation":[{"name":"University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu-Hsieh","family":"Hsu","sequence":"additional","affiliation":[{"name":"University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Davis","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3891-0942","authenticated-orcid":false,"given":"Eva","family":"Szabo","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention, National Cancer Institute, Bethesa, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Husted","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine, School of Medicine, Boston University, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqiao","family":"Liu","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine, School of Medicine, Boston University, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"LeClerc","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, School of Medicine, Boston University, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy O.","family":"Alekseyev","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, School of Medicine, Boston University, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-6796","authenticated-orcid":false,"given":"Gang","family":"Liu","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine, School of Medicine, Boston University, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1398-6636","authenticated-orcid":false,"given":"Julie E.","family":"Bauman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Arizona, Tucson, AZ 85724, USA"},{"name":"University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA"},{"name":"Division of Hematology\/Oncology, Department of Medicine, George Washington (GW) University and GW Cancer Center, Washington, DC 20037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avrum E.","family":"Spira","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine, School of Medicine, Boston University, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6699-2132","authenticated-orcid":false,"given":"Jennifer","family":"Beane","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine, School of Medicine, Boston University, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-7530","authenticated-orcid":false,"given":"Malgorzata","family":"Wojtowicz","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention, National Cancer Institute, Bethesa, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-H. Sherry","family":"Chow","sequence":"additional","affiliation":[{"name":"University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer Statistics 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amjmed.2012.01.017","article-title":"Low-dose Aspirin and Cancer Mortality: Of Randomized Trials","volume":"125","author":"Mills","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: A quantitative review to 2011","volume":"23","author":"Bosetti","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/1055-9965.EPI-08-1110","article-title":"Association of Nonsteroidal Anti-Inflammatory Drugs with Lung Cancer: Results from a Large Cohort Study","volume":"18","author":"Slatore","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/01902149809087389","article-title":"Inhibition of lung tumorigenesis by NSAIDS: A working hypothesis","volume":"24","author":"Castonguay","year":"1998","journal-title":"Exp. Lung Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3727\/096504009789745520","article-title":"Chemopreventive Effect of Nonsteroidal Anti-inflammatory Drugs on 9,10-Dimethylbenz[a]anthracene-Induced Lung Carcinogenesis in Mice","volume":"17","author":"Saini","year":"2009","journal-title":"Oncol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0192-0561(92)90182-K","article-title":"The Discovery and Development of Zileuton\u2014An Orally Active 5-Lipoxygenase Inhibitor","volume":"14","author":"Bell","year":"1992","journal-title":"Int. J. Immunopharmacol."},{"key":"ref_9","first-page":"929","article-title":"5-Lipoxygenase Inhibitory Activity of Zileuton","volume":"256","author":"Carter","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_10","first-page":"467","article-title":"Lipoxygenase inhibitors as potential cancer chemopreventives","volume":"8","author":"Steele","year":"1999","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1172\/JCI118480","article-title":"Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling","volume":"97","author":"Avis","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/carcin\/19.8.1393","article-title":"Inhibitors of lipoxygenase: A new class of cancer chemopreventive agents","volume":"19","author":"Rioux","year":"1998","journal-title":"Carcinogenesis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/01902149809087390","article-title":"Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth","volume":"24","author":"Moody","year":"1998","journal-title":"Exp. Lung Res."},{"key":"ref_14","first-page":"4199","article-title":"Chemoprevention by lipoxygenase and leukotriene pathway inhibitors of vinyl carbamate-induced lung tumors in mice","volume":"62","author":"Gunning","year":"2002","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/1940-6207.CAPR-13-0083","article-title":"Effect of Zileuton and Celecoxib on Urinary LTE4 and PGE-M Levels in Smokers","volume":"6","author":"Mohebati","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jnci\/89.12.857","article-title":"Clonal genetic alterations in the lungs of current and former smokers","volume":"89","author":"Mao","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00109-006-0103-z","article-title":"Modification of gene expression of the small airway epithelium in response to cigarette smoking","volume":"85","author":"Harvey","year":"2007","journal-title":"J. Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/1940-6207.CAPR-07-0017","article-title":"Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers","volume":"1","author":"Zhang","year":"2008","journal-title":"Cancer Prev. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1038\/s41598-019-43295-3","article-title":"Tobacco-related alterations in airway gene expression are rapidly reversed within weeks following smoking-cessation","volume":"9","author":"Hijazi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1164\/rccm.201208-1449OC","article-title":"A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment","volume":"187","author":"Steiling","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12931-017-0696-5","article-title":"Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression","volume":"18","author":"Boudewijn","year":"2017","journal-title":"Respir. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1158\/1078-0432.CCR-16-2540","article-title":"Detecting the presence and progression of premalignant lung lesions via airway gene expression","volume":"23","author":"Beane","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"26ra25","DOI":"10.1126\/scitranslmed.3000251","article-title":"Airway PI3K pathway activation is an early and reversible event in lung cancer development","volume":"2","author":"Gustafson","year":"2010","journal-title":"Sci. Trans. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/s41467-019-09834-2","article-title":"Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions","volume":"10","author":"Beane","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1940-6207.CAPR-11-0212","article-title":"Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq","volume":"4","author":"Beane","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sridhar, S., Schembri, F., Zeskind, J., Shah, V., Gustafson, A.M., Steiling, K., Liu, G., Dumas, Y.M., Zhang, X., and Brody, J.S. (2008). Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genom., 30.","DOI":"10.1186\/1471-2164-9-259"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"AEGIS Study Team (2017). Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection. J. Natl. Cancer Inst., 109, djw327.","DOI":"10.1093\/jnci\/djw327"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1158\/1940-6207.CAPR-19-0036","article-title":"Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial","volume":"12","author":"Garland","year":"2019","journal-title":"Cancer Prev. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physiolgenomics.00167.2009","article-title":"Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium","volume":"41","author":"Zhang","year":"2010","journal-title":"Physiol. Genom."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1186\/gb-2007-8-9-r201","article-title":"Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression","volume":"8","author":"Beane","year":"2007","journal-title":"Genome Biol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Whitney, D.H., Elashoff, M.R., Porta-Smith, K., Gower, A.C., Vachani, A., Ferguson, J.S., Silvestri, G.A., Brody, J.S., Lenburg, M.E., and Spira, A. (2015). Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy. BMC Med. Genom., 8.","DOI":"10.1186\/s12920-015-0091-3"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ab.2004.08.019","article-title":"Quantification of the major urinary metabolite of PGE(2) by a liquid chromatographic\/mass spectrometric assay: Determination of cyclo oxygenase-specific PGE(2) synthesis in healthy humans and those with lung cancer","volume":"334","author":"Murphey","year":"2004","journal-title":"Anal. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1158\/1940-6207.CAPR-09-0005","article-title":"Levels of Prostaglandin E Metabolite and Leukotriene E-4 Are Increased in the Urine of Smokers: Evidence that Celecoxib Shunts Arachidonic Acid into the 5-Lipoxygenase Pathway","volume":"2","author":"Boyle","year":"2009","journal-title":"Cancer Prev. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1093\/bioinformatics\/bts588","article-title":"fRMA ST: Frozen robust multiarray analysis for Affymetrix Exon and Gene ST arrays","volume":"28","author":"McCall","year":"2012","journal-title":"Bioinformatics"},{"key":"ref_35","unstructured":"(2022, April 19). Available online: http:\/\/brainarray.mbni.med.umich.edu\/Brainarray\/Database\/CustomCDF\/genomic_curated_CDF.asp."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic. Acids. Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Chen, C., Grennan, K., Badner, J., Zhang, D., Gershon, E., Jin, L., and Liu, C. (2011). Removing batch effects in analysis of expression microarray data: An evaluation of six batch adjustment methods. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017238"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"H\u00e4nzelmann, S., Castelo, R., and Guinney, J. (2013). GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-7"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e190185","DOI":"10.1001\/jamanetworkopen.2019.0185","article-title":"Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer","volume":"2","author":"Ye","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: Analysis of individual patient data from randomized trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"ref_43","first-page":"1531","article-title":"Modulation by aspirin and naproxen of nucleotide alterations and tumors in the lung of mice exposed to environmental cigarette smoke since birth","volume":"36","author":"Izzotti","year":"2015","journal-title":"Carcinogenesis"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"85716","DOI":"10.18632\/oncotarget.20464","article-title":"Early and late effects of aspirin and naproxen on microRNAs in the lung and blood of mice, either unexposed or exposed to cigarette smoke","volume":"8","author":"Izzotti","year":"2017","journal-title":"Oncotarget"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2165\/00003088-199500292-00007","article-title":"The pharmacokinetics of zileuton in healthy young and elderly volunteers","volume":"29","author":"Braeckman","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1172\/JCI92885","article-title":"Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males","volume":"127","author":"Pace","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.10.025","article-title":"Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model","volume":"79","author":"Liu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1098-8823(03)00039-X","article-title":"The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy","volume":"71","author":"Celotti","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/12\/2893\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:28:14Z","timestamp":1760138894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/12\/2893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["cancers14122893"],"URL":"https:\/\/doi.org\/10.3390\/cancers14122893","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]}}}